Case Report - (2015) Volume 6, Issue 2
Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease
- Erick Rivera-Grana1, Phoebe Lin2, Eric B. Suhler2,3 and James T Rosenbaum2,4*
- 1Ponce Health Sciences University, Ponce, Puerto Rico
- 2Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA
- 3Portland VA Health Care System, Portland, Oregon, USA
- 4Legacy Devers Eye Institute, Portland, Oregon, USA
*Corresponding Author:
James T Rosenbaum, Oregon Health & Science University, Casey Eye Institute And Legacy Devers Eye Institute, Portland, Oregon, USA, Tel: 503 494 5023, Fax: 503 494 6875
Email:
